Press release – For immediate release– 05:45 pm CEST
Median Technologies reschedules its Corporate Update webcasts on May 4, 2023
Median Technologies (ALMDT:PA) announced today that the two webcasts during which Fredrik Brag, CEO and Founder will provide a corporate update, are rescheduled from May 3rd to May 4th, 2023. New registration links are below.
- Webcast held in English: at 4:00 pm CEST / 10:00 am EDT – Registration link: https://register.gotowebinar.com/register/7324060688550180191
- Webcast held in French: at 6:00 pm CEST / 12:00 pm EDT – Registration link: https://register.gotowebinar.com/register/4126422489745055066
Webcast replays will be available on Median’s corporate website after the live sessions.
Pioneering innovative imaging solutions and services, Median Technologies harnesses cutting-edge AI to enhance the accuracy of early cancer diagnoses and treatments. Median’s offerings include iCRO, which provides medical image analysis and management in oncology trials, and eyonis™, an AI/ML tech-based suite of software as medical devices (SaMD). Median empowers biopharmaceutical entities and clinicians to advance patient care and expedite the development of novel therapies. The French-based company, with a presence in the U.S. and China, trades on the Euronext Growth market (ISIN: FR0011049824, ticker: ALMDT). Median is also eligible for the French SME equity savings plan scheme (PEA-PME). For more information, visit